Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast

Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.